Clofarabine - Latest Advances

Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.

Journal: JCO precision oncology

Published: October 02, 2025

Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.

Journal: Pediatric hematology and oncology

Published: September 24, 2025

Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.

Journal: Bioorganic & medicinal chemistry letters

Published: June 20, 2025

Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights.

Journal: Molecular therapy. Nucleic acids

Published: June 02, 2025

Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina.

Journal: Investigative ophthalmology & visual science

Published: May 28, 2025

Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report.

Journal: Cureus

Published: May 18, 2025

Conditioning regimens in pediatric myeloid malignancies undergoing allogeneic HSCT: a comparative single-center study.

Journal: Frontiers in oncology

Published: May 06, 2025

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

Journal: British journal of haematology

Published: March 08, 2025

High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System.

Journal: Molecules (Basel, Switzerland)

Published: February 26, 2025

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: February 17, 2025

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: February 17, 2025

Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial.

Journal: EClinicalMedicine

Published: February 04, 2025

Filters

Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.

Interactive Use of Cox Model-Predicted Survival Curves: An Application Using ACS10 Score and Age to Personalize Treatment of Pediatric AML.

Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.

Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement.

Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.

Discovery of a novel non-toxic analog of clofarabine for the treatment of triple-negative breast cancer.

Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights.

Exploring adenosine analogs for chondrosarcoma therapy: In vitro and in vivo insights.

Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina.

Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina.

Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report.

Novel Combination Therapy With Lenalidomide and Trametinib for Treatment-Resistant Xanthoma Disseminatum With Disabling Cutaneous and Synovial Involvement: A Case Report.

Conditioning regimens in pediatric myeloid malignancies undergoing allogeneic HSCT: a comparative single-center study.

Conditioning regimens in pediatric myeloid malignancies undergoing allogeneic HSCT: a comparative single-center study.

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II study.

High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System.

High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System.

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Identification of anticancer drugs associated to cancer therapy-related cardiac dysfunction: a VigiBase® disproportionality analysis.

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis.

Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial.

Mitoxantrone in combination with clofarabine (MITCL) in children, adolescents and young adults with relapsed/refractory acute leukaemia: final results of a phase I/II trial.